Europe Cardiac Biomarkers Testing Market (2019-2025)
The Europe Cardiac Biomarkers Testing Market would witness market growth of 11.1% CAGR during the forecast period (2019–2025).
The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain has added a boost to market growth. Additionally, promising features like high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing is further driving the growth of the market across the globe. To keep the momentum of cardiac marker tests, the key manufacturers offer customized solutions. The commercial application of multi-menu options, which are meant for cardiac testing done through different combinations of cardiac biomarkers and target-oriented solutions, are the major opportunities of the market. However, limited specificity in some cases and side effects such as skeletal muscle injury is restraining the growth cardiac biomarkers markets.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
Market Segmentation:
By Type
The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain has added a boost to market growth. Additionally, promising features like high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing is further driving the growth of the market across the globe. To keep the momentum of cardiac marker tests, the key manufacturers offer customized solutions. The commercial application of multi-menu options, which are meant for cardiac testing done through different combinations of cardiac biomarkers and target-oriented solutions, are the major opportunities of the market. However, limited specificity in some cases and side effects such as skeletal muscle injury is restraining the growth cardiac biomarkers markets.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
Market Segmentation:
By Type
- Creatine Kinase (CK-MB)
- Troponins
- Myoglobin
- Natriuretic Peptides (BNP and NT-proBNP)
- Ischemia Modified Albumin
- Others
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- Point of Care Testing
- Laboratory Testing
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Trivitron Healthcare Pvt. Ltd.
- Abbott Laboratories
- Siemens AG
- Becton, Dickinson AND Company
- Bio-Rad Laboratories, Inc.
- Randox Laboratories Limited
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Johnson and Johnson
- Quidel Corporation
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cardiac Biomarkers Testing Market, by Type
1.4.2 Europe Cardiac Biomarkers Testing Market, by Application
1.4.3 Europe Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 Europe Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
CHAPTER 3. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE
3.1.1 Europe Creatine Kinase (CK-MB) Market by Country
3.1.2 Europe Troponins Market by Country
3.1.3 Europe Myoglobin Market by Country
3.1.4 Europe Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 Europe Ischemia Modified Albumin Market by Country
3.1.6 Europe Others Market by Country
CHAPTER 4. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION
4.1.1 Europe Myocardial Infarction Market by Country
4.1.2 Europe Congestive Heart Failure Market by Country
4.1.3 Europe Acute Coronary Syndrome Market by Country
4.1.4 Europe Atherosclerosis Market by Country
4.1.5 Europe Others Market by Country
CHAPTER 5. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING
5.1.1 Europe Point of Care Testing Market by Country
5.1.2 Europe Laboratory Testing Market by Country
CHAPTER 6. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY
6.1 Germany Cardiac Biomarkers Testing Market
6.1.1 Germany Cardiac Biomarkers Testing Market by Type
6.1.2 Germany Cardiac Biomarkers Testing Market by Application
6.1.3 Germany Cardiac Biomarkers Testing Market by Location of Testing
6.2 UK Cardiac Biomarkers Testing Market
6.2.1 UK Cardiac Biomarkers Testing Market by Type
6.2.2 UK Cardiac Biomarkers Testing Market by Application
6.2.3 UK Cardiac Biomarkers Testing Market by Location of Testing
6.2.4 France Cardiac Biomarkers Testing Market
6.2.5 France Cardiac Biomarkers Testing Market by Type
6.2.6 France Cardiac Biomarkers Testing Market by Application
6.2.7 France Cardiac Biomarkers Testing Market by Location of Testing
6.3 Russia Cardiac Biomarkers Testing Market
6.3.1 Russia Cardiac Biomarkers Testing Market by Type
6.3.2 Russia Cardiac Biomarkers Testing Market by Application
6.3.3 Russia Cardiac Biomarkers Testing Market by Location of Testing
6.4 Spain Cardiac Biomarkers Testing Market
6.4.1 Spain Cardiac Biomarkers Testing Market by Type
6.4.2 Spain Cardiac Biomarkers Testing Market by Application
6.4.3 Spain Cardiac Biomarkers Testing Market by Location of Testing
6.5 Italy Cardiac Biomarkers Testing Market
6.5.1 Italy Cardiac Biomarkers Testing Market by Type
6.5.2 Italy Cardiac Biomarkers Testing Market by Application
6.5.3 Italy Cardiac Biomarkers Testing Market by Location of Testing
6.6 Rest of Europe Cardiac Biomarkers Testing Market
6.6.1 Rest of Europe Cardiac Biomarkers Testing Market by Type
6.6.2 Rest of Europe Cardiac Biomarkers Testing Market by Application
6.6.3 Rest of Europe Cardiac Biomarkers Testing Market by Location of Testing
CHAPTER 7. COMPANY PROFILES
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cardiac Biomarkers Testing Market, by Type
1.4.2 Europe Cardiac Biomarkers Testing Market, by Application
1.4.3 Europe Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 Europe Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
CHAPTER 3. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE
3.1.1 Europe Creatine Kinase (CK-MB) Market by Country
3.1.2 Europe Troponins Market by Country
3.1.3 Europe Myoglobin Market by Country
3.1.4 Europe Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 Europe Ischemia Modified Albumin Market by Country
3.1.6 Europe Others Market by Country
CHAPTER 4. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION
4.1.1 Europe Myocardial Infarction Market by Country
4.1.2 Europe Congestive Heart Failure Market by Country
4.1.3 Europe Acute Coronary Syndrome Market by Country
4.1.4 Europe Atherosclerosis Market by Country
4.1.5 Europe Others Market by Country
CHAPTER 5. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING
5.1.1 Europe Point of Care Testing Market by Country
5.1.2 Europe Laboratory Testing Market by Country
CHAPTER 6. EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY
6.1 Germany Cardiac Biomarkers Testing Market
6.1.1 Germany Cardiac Biomarkers Testing Market by Type
6.1.2 Germany Cardiac Biomarkers Testing Market by Application
6.1.3 Germany Cardiac Biomarkers Testing Market by Location of Testing
6.2 UK Cardiac Biomarkers Testing Market
6.2.1 UK Cardiac Biomarkers Testing Market by Type
6.2.2 UK Cardiac Biomarkers Testing Market by Application
6.2.3 UK Cardiac Biomarkers Testing Market by Location of Testing
6.2.4 France Cardiac Biomarkers Testing Market
6.2.5 France Cardiac Biomarkers Testing Market by Type
6.2.6 France Cardiac Biomarkers Testing Market by Application
6.2.7 France Cardiac Biomarkers Testing Market by Location of Testing
6.3 Russia Cardiac Biomarkers Testing Market
6.3.1 Russia Cardiac Biomarkers Testing Market by Type
6.3.2 Russia Cardiac Biomarkers Testing Market by Application
6.3.3 Russia Cardiac Biomarkers Testing Market by Location of Testing
6.4 Spain Cardiac Biomarkers Testing Market
6.4.1 Spain Cardiac Biomarkers Testing Market by Type
6.4.2 Spain Cardiac Biomarkers Testing Market by Application
6.4.3 Spain Cardiac Biomarkers Testing Market by Location of Testing
6.5 Italy Cardiac Biomarkers Testing Market
6.5.1 Italy Cardiac Biomarkers Testing Market by Type
6.5.2 Italy Cardiac Biomarkers Testing Market by Application
6.5.3 Italy Cardiac Biomarkers Testing Market by Location of Testing
6.6 Rest of Europe Cardiac Biomarkers Testing Market
6.6.1 Rest of Europe Cardiac Biomarkers Testing Market by Type
6.6.2 Rest of Europe Cardiac Biomarkers Testing Market by Application
6.6.3 Rest of Europe Cardiac Biomarkers Testing Market by Location of Testing
CHAPTER 7. COMPANY PROFILES
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
LIST OF TABLES
TABLE 1 EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 UK CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 UK CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 76 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 77 ITALY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 ITALY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 82 ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 83 ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 84 ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 94 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 95 KEY INFORMATION – SIEMENS AG
TABLE 96 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 97 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 98 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 99 KEY INFORMATION – DANAHER CORPORATION
TABLE 100 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 101 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 102 KEY INFORMATION – QUIDEL CORPORATION
TABLE 1 EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 UK CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 UK CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 70 SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 71 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 76 SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 77 ITALY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 78 ITALY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 79 ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 82 ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 83 ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 84 ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 94 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 95 KEY INFORMATION – SIEMENS AG
TABLE 96 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 97 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 98 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 99 KEY INFORMATION – DANAHER CORPORATION
TABLE 100 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 101 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 102 KEY INFORMATION – QUIDEL CORPORATION
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON
